Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Dec 10, 2025 · Ragosa Mark sold 42.84K shares at $41.49/share ($1.8M); exercised options for 42.84K shares

Ragosa Mark sold 42.84K shares at $41.49/share ($1.8M); exercised options for 42.84K shares

xslF345X05/form4-12102025_101258.xml

xslF345X05/form4-12102025_101258.xmlSEC.gov

Graphics and non-inline formats (not embedded below).